Succinimide Formation from an NGR-Containing Cyclic Peptide: Computational Evidence for Catalytic Roles of Phosphate Buffer and the Arginine Side Chain
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Succinimide Formation from an NGR-Containing Cyclic Peptide: Computational Evidence for Catalytic Roles of Phosphate Buffer and the Arginine Side Chain
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 2, Pages 429
Publisher
MDPI AG
Online
2017-02-17
DOI
10.3390/ijms18020429
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Therapies in Phase II and III Trials for Malignant Pleural Mesothelioma
- (2017) Marjorie G. Zauderer et al. Journal of the National Comprehensive Cancer Network
- A Computational Study of the Mechanism of Succinimide Formation in the Asn–His Sequence: Intramolecular Catalysis by the His Side Chain
- (2016) Ohgi Takahashi et al. MOLECULES
- NGR-tagged nano-gold: A new CD13-selective carrier for cytokine delivery to tumors
- (2016) Flavio Curnis et al. Nano Research
- Systemic and tumor-targeted delivery of siRNA by cyclic NGR and isoDGR motif-containing peptides
- (2016) Yuanyu Huang et al. Biomaterials Science
- Exploiting cytokines in adoptive T-cell therapy of cancer
- (2015) Elisabetta Petrozziello et al. Immunotherapy
- Glycolic Acid-Catalyzed Deamidation of Asparagine Residues in Degrading PLGA Matrices: A Computational Study
- (2015) Noriyoshi Manabe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma
- (2015) Guendalina Zuccari et al. JOURNAL OF CONTROLLED RELEASE
- Development of Cyclic NGR Peptides with Thioether Linkage: Structure and Dynamics Determining Deamidation and Bioactivity
- (2015) Kata Nóra Enyedi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Vascular-homing peptides for targeted drug delivery and molecular imaging: Meeting the clinical challenges
- (2014) Nunzia D'Onofrio et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- A Unified Mechanism for Aminopeptidase N-based Tumor Cell Motility and Tumor-homing Therapy
- (2014) Chang Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Specific Catalysis of Asparaginyl Deamidation by Carboxylic Acids: Kinetic, Thermodynamic, and Quantitative Structure–Property Relationship Analyses
- (2014) Brian D. Connolly et al. MOLECULAR PHARMACEUTICS
- A pilot Phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma
- (2014) Giorgio Parmiani et al. OncoImmunology
- Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example
- (2013) Angelo Corti et al. BIODRUGS
- CyclicisoDGR Peptidomimetics as Low-Nanomolar αvβ3Integrin Ligands
- (2013) Michele Mingozzi et al. CHEMISTRY-A EUROPEAN JOURNAL
- Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma
- (2013) Daniela Di Paolo et al. JOURNAL OF CONTROLLED RELEASE
- Molecular Dynamics Reveal that isoDGR-Containing Cyclopeptides Are True αvβ3 Antagonists Unable To Promote Integrin Allostery and Activation
- (2012) Michela Ghitti et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- NGR-based Strategies for Targeting Delivery of Chemotherapeutics to Tumor Vasculature
- (2012) Mingming Zou et al. Anti-Cancer Agents in Medicinal Chemistry
- Phase I and pharmacodynamic study of high-dose NGR–hTNF in patients with refractory solid tumours
- (2012) P A Zucali et al. BRITISH JOURNAL OF CANCER
- Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients
- (2012) D Lorusso et al. BRITISH JOURNAL OF CANCER
- Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery
- (2012) Zhi Li et al. Journal of Translational Medicine
- TumorHoPe: A Database of Tumor Homing Peptides
- (2012) Pallavi Kapoor et al. PLoS One
- IsoDGR-Tagged Albumin: A New αvβ3 Selective Carrier for Nanodrug Delivery to Tumors
- (2012) Flavio Curnis et al. Small
- NGR Peptide Ligands for Targeting CD13/APN Identified through Peptide Array Screening Resemble Fibronectin Sequences
- (2012) Rania Soudy et al. ACS Combinatorial Science
- Use of Metadynamics in the Design of isoDGR-Based αvβ3 Antagonists To Fine-Tune the Conformational Ensemble
- (2011) Andrea Spitaleri et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Phase I Study of NGR-hTNF, a Selective Vascular Targeting Agent, in Combination with Cisplatin in Refractory Solid Tumors
- (2011) V. Gregorc et al. CLINICAL CANCER RESEARCH
- Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
- (2011) Angelo Corti et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Isoaspartate-dependent molecular switches for integrin-ligand recognition
- (2011) A. Corti et al. JOURNAL OF CELL SCIENCE
- APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes
- (2011) Michael Dunne et al. JOURNAL OF CONTROLLED RELEASE
- Targeted Drug Delivery and Penetration Into Solid Tumors
- (2011) Angelo Corti et al. MEDICINAL RESEARCH REVIEWS
- Anti-tumor efficacy and pre-clinical immunogenicity of IFNα2a-NGR
- (2011) Baolai Zhang et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Conformational Control of Integrin-Subtype Selectivity in isoDGR Peptide Motifs: A Biological Switch
- (2010) Andreas O. Frank et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- 2D TR-NOESY Experiments Interrogate and Rank Ligand-Receptor Interactions in Living Human Cancer Cells
- (2010) Silvia Mari et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Bioreducible BPEI-SS-PEG-cNGR polymer as a tumor targeted nonviral gene carrier
- (2010) Sejin Son et al. BIOMATERIALS
- Synthesis and in vivo evaluation of Tc-99m-labeled cyclic CisoDGRC peptide conjugates for targeting αvβ3 integrin expression
- (2010) Gopal Pathuri et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Aminopeptidase N (CD13) as a target for cancer chemotherapy
- (2010) Malin Wickström et al. CANCER SCIENCE
- Phase I Clinical and Magnetic Resonance Imaging Study of the Vascular Agent NGR-hTNF in Patients with Advanced Cancers (European Organization for Research and Treatment of Cancer Study 16041)
- (2010) H. W.M. van Laarhoven et al. CLINICAL CANCER RESEARCH
- Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy
- (2010) Armando Santoro et al. EUROPEAN JOURNAL OF CANCER
- Critical Role of Flanking Residues in NGR-to-isoDGR Transition and CD13/Integrin Receptor Switching
- (2010) Flavio Curnis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma
- (2010) Vanesa Gregorc et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma
- (2010) Monica Loi et al. JOURNAL OF CONTROLLED RELEASE
- Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience
- (2009) R. Bieker et al. BLOOD
- A novel DDS strategy, “dual-targeting”, and its application for antineovascular therapy
- (2009) Yuki Murase et al. CANCER LETTERS
- Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours
- (2009) Vanesa Gregorc et al. EUROPEAN JOURNAL OF CANCER
- Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid
- (2009) B Jullienne et al. GENE THERAPY
- NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells
- (2009) Xun Wang et al. JOURNAL OF CONTROLLED RELEASE
- A Universal Approach to Solvation Modeling
- (2008) Christopher J. Cramer et al. ACCOUNTS OF CHEMICAL RESEARCH
- The neovasculature homing motif NGR: more than meets the eye
- (2008) A. Corti et al. BLOOD
- Synergistic Damage of Tumor Vessels with Ultra Low-Dose Endothelial-Monocyte Activating Polypeptide-II and Neovasculature-Targeted Tumor Necrosis Factor-
- (2008) L. Crippa et al. CANCER RESEARCH
- Isoaspartate-Glycine-Arginine: A New Tumor Vasculature-Targeting Motif
- (2008) F. Curnis et al. CANCER RESEARCH
- Quantitative Molecular Magnetic Resonance Imaging of Tumor Angiogenesis Using cNGR-Labeled Paramagnetic Quantum Dots
- (2008) M. Oostendorp et al. CANCER RESEARCH
- Structural Basis for the Interaction ofisoDGR with the RGD-binding Site of αvβ3 Integrin
- (2008) Andrea Spitaleri et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Performance of SM8 on a Test To Predict Small-Molecule Solvation Free Energies
- (2008) Adam C. Chamberlin et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFN
- (2008) A. M. Gasparri et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started